Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

Topline data from phase II/III registration study of pegloprastide

Aug. 5, 2020

First-in-human study of [124I]JS-001 PET/CT and PET/MR in patients with melanoma

Aug. 5, 2020

AC Immune describes enhanced alpha-synuclein PET tracers

Aug. 5, 2020

Gallium-68-labeled denosumab synthesized for PET imaging of tumor microenvironment

Aug. 5, 2020

French researchers disclose TfR1-targeting antibodies

Aug. 4, 2020

Clinical evaluation of [18F]EKZ-001 PET radiotracer to quantify HDAC6 brain expression

July 31, 2020

[18F]SMBT-1 shows promise for imaging astrogliosis in Alzheimer's disease

July 31, 2020

[89Zr]DFO-elotuzumab as novel imaging agent in patients with MM

July 29, 2020

[124/131I]-MSK-PSMA1, a new radioiodinated theranostic agent for PSMA-positive prostate cancer

July 29, 2020

Adenosine A2A receptor PET radiotracer [18F]FLUDA characterized in vitro and in vivo

July 28, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.